Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
56 |
|
| Actual shortage: | 30 (54%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 26 (46%) | |
Discontinuation Reports |
10 |
|
| To be discontinued: | 10 (100%) | |
| Discontinued: | 0 (0%) | |
| Reversed: | 0 (0%) | |
Late reports |
1 (2%) |
|
Overdue reports |
1 (3%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-BOSENTAN | 62.5MG | TABLET | Actual shortage | 2024-11-18 | 2025-07-03 | 243351 |
| NAT-BOSENTAN | 125MG | TABLET | Actual shortage | 2024-11-18 | 2025-07-03 | 243354 |
| NAT-CETIRIZINE | 10MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271170 |
| NAT-CETIRIZINE | 20MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271178 |
| NATCO-CITALOPRAM | 10MG | TABLET | Resolved | 2018-11-23 | 2019-02-04 | 67518 |
| NAT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-11-08 | 2024-11-12 | 242394 |
| NAT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-11-11 | 2024-11-12 | 242436 |
| NAT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-11-11 | 2024-11-12 | 242439 |
| NAT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-11-11 | 2024-11-12 | 242445 |
| NAT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-11-11 | 2024-11-12 | 242448 |
| NAT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-11-11 | 2024-11-12 | 242451 |
| NAT-DONEPEZIL | 5MG | TABLET | Resolved | 2018-07-13 | 2020-10-26 | 55625 |
| NAT-DONEPEZIL | 5MG | TABLET | Resolved | 2024-02-02 | 2024-02-21 | 218262 |
| NAT-DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-04-29 | 2025-07-03 | 226585 |
| NAT-DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-06-13 | 2025-07-03 | 230392 |
| NAT-DONEPEZIL | 10MG | TABLET | Resolved | 2018-07-13 | 2020-10-26 | 55630 |
| NAT-DONEPEZIL | 10MG | TABLET | Actual shortage | 2025-04-04 | 2025-07-03 | 254178 |
| NAT-ERIBULIN | 0.5MG | SOLUTION | Actual shortage | 2025-08-21 | 2025-08-22 | 265770 |
| NAT-ERLOTINIB | 25MG | TABLET | Actual shortage | 2020-12-03 | 2024-12-16 | 129536 |
| NAT-ERLOTINIB | 100MG | TABLET | Actual shortage | 2020-12-03 | 2024-12-16 | 129550 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-DONEPEZIL | 5MG | TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273383 |
| NAT-DONEPEZIL | 10MG | TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273387 |
| NAT-LEVETIRACETAM | 250MG | TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273390 |
| NAT-LEVETIRACETAM | 500MG | TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273434 |
| NAT-LEVETIRACETAM | 750MG | TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273437 |
| NAT-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | To be discontinued | 2025-12-05 | 2025-12-05 | 273440 |
| NAT-QUETIAPINE | 25MG | TABLET (IMMEDIATE RELEASE) TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273482 |
| NAT-QUETIAPINE | 100MG | TABLET (IMMEDIATE RELEASE) TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273489 |
| NAT-QUETIAPINE | 200MG | TABLET (IMMEDIATE RELEASE) TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273496 |
| NAT-QUETIAPINE | 300MG | TABLET (IMMEDIATE RELEASE) TABLET | To be discontinued | 2025-12-05 | 2025-12-05 | 273501 |
Showing 1 to 10 of 10